Eli Lilly and Co
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Novo Nordisk and Eli Lilly shares slid Wednesday after Roche announced promising early-stage trial data from its latest obesity drug candidate. The Swiss pharmaceutical giant said Wednesday that a second drug candidate from its purchase of Carmot Therapeutics indicated positive results, further heating up competition in the weight loss drug market. Roche shares jumped in […]
Read More
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Novo Nordisk‘s blockbuster diabetes drug Ozempic may have more to offer beyond […]
Read More
CNBC Pro Talks: From weight loss drugs to AI winners, CIO set to reveal his top stocks
Weight loss drugs and artificial intelligence have been dominating headlines, with investors betting that stocks in both categories have big potential upside. On Wednesday’s Pro Talks , CNBC’s Senior Technology Correspondent Arjun Kharpal will ask Tema ETFs’ Yuri Khodjamirian how to best invest in these areas and more. Got a question for Khodjamirian? Submit it […]
Read More
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Several drugmakers are hurrying to capitalize on one of the next major innovations coming to the booming weight loss drug market: effective, convenient and potentially affordable obesity pills. Most of the […]
Read More
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it saw “encouraging” data in an ongoing early-stage trial. The company evaluated several once-daily formulations of the drug and identified one with “the most favorable profile.” Pfizer said it […]
Read More
FTC to sue drug middlemen over prices of medications including insulin
FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled “Fiscal Year 2025 Request for the Federal Trade Commission,” in Rayburn Building on Wednesday, May 15, 2024. Tom Williams | CQ-Roll Call, Inc. | Getty Images The Federal Trade Commission is planning to sue three large U.S. […]
Read More
Stocks making the biggest moves midday: Nvidia, Corning, Helen of Troy, UiPath and more
Check out the companies making headlines in midday trading: Nvidia — Shares of the artificial intelligence darling popped 1.8% following KeyBanc’s price target hike to $180, which implies about 40% upside from Monday’s close. The firm said demand for Nvidia’s H100 chip “remains robust” even with the imminent launch of Blackwell in the second half […]
Read More
Shares making the most important moves midday: Paramount World, Morphic Holding, Ideaya Biosciences and additional
Test out the businesses building headlines in midday buying and selling. Paramount World wide — The media and entertainment enterprise lose 2% immediately after it agreed to merge with Skydance Media . Skydance and its economical backers will devote much more than $8 billion into Paramount and to obtain National Amusements, Paramount’s managing shareholder. Morphic […]
Read More
Shares earning the largest moves premarket: Paramount, SolarEdge, Morphic Holding and more
Check out out the corporations producing headlines before the bell. Morphic Holding — Shares surged additional than 75% on information that Eli Lilly will get the biopharma enterprise in a $3.2 billion offer . The offer will give Eli Lilly entry to Morphic’s portfolio of therapies in enhancement, these types of as individuals for ulcerative […]
Read More
This ETF is trying to satisfy appetites for bodyweight decline shares
ETF Edge This ETF is seeking to fulfill appetites for weight loss shares Released Sat, Jul 6 202411:00 AM EDT Ellie Stevens@elliestevens02 Enjoy Are living Supply
Read More